Universal HIV testing: Is it enough?

Clinical Infectious Diseases

Volumn 45, Issue 10, 2007, Pages 1375-1376

  Goicoechea, M ^a   Smith, Davey M ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MEDICAL CARE; NOTE; PRENATAL CARE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; TREATMENT OUTCOME; DIAGNOSTIC TEST; HEALTH INSURANCE; PATIENT; UTILIZATION REVIEW;

DIAGNOSTIC TESTS, ROUTINE; HIV INFECTIONS; HUMANS; INSURANCE, HEALTH; MEDICALLY UNINSURED;

EID: 36048967035     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522760     Document Type: Note

References (17)

1. May M, Sterne JA, Sabin C, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007; 21:1185-97.
2. Barroso PF, Schechter M, Gupta P, et al. Effect of antiretroviral therapy on HIV shedding in semen. Ann Intern Med 2000; 133:280-4.
3. Keruly JC, Moore RD. Immune status at presentation to care has not improved among antiretroviral-naive persons from 1990 to 2006. Clin Infect Dis 2007; 45:1369-74 (in this issue).
4. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55:1-17; quiz CE1-4.
5. Anderson JE, Chandra A, Mosher WD. HIV testing in the United States, 2002. Adv Data 2005; 363:1-32.
6. McInnes K, Landon BE, Malitz FE, et al. Differences in patient and clinic characteristics at CARE Act funded versus non-CARE Act funded HIV clinics. AIDS Care 2004; 16: 851-7.
7. Anderson JE, Sansom S. HIV testing among US women during prenatal care: findings from the 2002 National Survey of Family Growth. Matern Child Health J 2006; 10:413-7.
8. Wotring LL, Montgomery JP, Mokotoff ED, Inungu JN, Markowitz N, Crane LR. Pregnancy and other factors associated with higher CD4+ T-cell counts at HIV diagnosis in Southeast Michigan, 1992-2002. MedGenMed 2005; 7:1.
9. Warner LA, Wei W, McSpiritt E, Sambamoorthi U, Crystal S. Ante- and postpartum substance abuse treatment and antiretroviral therapy among HIV-infected women on Medicaid. J Am Med Womens Assoc 2003; 58:143-53.
10. Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001; 91:1060-8.
11. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 1998; 339:1897-904.
12. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43:27-34.
13. Castilla J, Lorenzo JM, Izquierdo A, et al. Characteristics and trends of newly diagnosed HIV-infections, 2000-2004. Gac Sanit 2006; 20:442-8.
14. Delpierre C, Cuzin L, Lert F. Routine testing to reduce late HIV diagnosis in France. BMJ 2007; 334:1354-6.
15. Gilbart VL, Dougan S, Sinka K, Evans BG. Late diagnosis of HIV infection among individuals with low, unrecognised, or unacknowledged risks in England, Wales, and Northern Ireland. AIDS Care 2006; 18:133-9.
16. Longo B, Pezzotti P, Boros S, Urciuoli R, Rezza G. Increasing proportion of late testers among AIDS cases in Italy, 1996-2002. AIDS Care 2005; 17:834-41.
17. Egger M. Outcomes of ART in resource-limited and industrialized countries [abstract 62]. In: 14th Conference on Retroviruses and Opportunistic Infections (Los Angeles). Alexandria, VA: Foundation for Retroviruses and Human Health, 2007:87.